Clinical Trial Update: Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating pamrevlumab plus systemic corticosteroids in ambulatory Duchenne muscular dystrophy was terminated, and trial results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Pamrevlumab (pamrevlumab)

Snippet

Sponsor: Kyntra Bio | Conditions: Duchenne Muscular Dystrophy | Phase 3 | Status: TERMINATED | Results posted: 2024-08-26